These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 3284969)

  • 1. Treatment of obsessive-compulsive disorder.
    Dominguez RA; Goldstein BJ
    J Fla Med Assoc; 1988 Feb; 75(2):91-4. PubMed ID: 3284969
    [No Abstract]   [Full Text] [Related]  

  • 2. Clomipramine in obsessive compulsive disorder.
    Lee S
    J Clin Psychiatry; 1991 Apr; 52(4):183-5. PubMed ID: 2016256
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of obsessive compulsive neurosis].
    Greenberg D; Shahar A
    Harefuah; 1985 Mar; 108(5):231-5. PubMed ID: 4007678
    [No Abstract]   [Full Text] [Related]  

  • 4. Psychopharmacologic treatment of obsessive-compulsive disorder.
    Thorneloe WF
    J Med Assoc Ga; 1988 Nov; 77(11):825-6. PubMed ID: 3057098
    [No Abstract]   [Full Text] [Related]  

  • 5. Obsessive compulsive disorder.
    J Clin Psychiatry; 1989 Jun; 50(6):231-2. PubMed ID: 2498297
    [No Abstract]   [Full Text] [Related]  

  • 6. Obsessive-compulsive disorder.
    Insel TR
    Psychiatr Clin North Am; 1985 Mar; 8(1):105-17. PubMed ID: 3887336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The role of drug therapy in the treatment of obsessive-compulsive disorders].
    Teeuwisse JM; Nolen WA
    Ned Tijdschr Geneeskd; 1989 Dec; 133(52):2605-8. PubMed ID: 2575230
    [No Abstract]   [Full Text] [Related]  

  • 8. Interim analysis clarification.
    Liebowitz MR; Foa EB; Kozak MJ
    J Clin Psychiatry; 1995 Sep; 56(9):435. PubMed ID: 7665548
    [No Abstract]   [Full Text] [Related]  

  • 9. Clomipramine in obsessive-compulsive disorder: a review.
    Ananth J
    Psychosomatics; 1983 Aug; 24(8):723-7. PubMed ID: 6356210
    [No Abstract]   [Full Text] [Related]  

  • 10. Fluvoxamine versus clomipramine in the treatment of obsessive compulsive disorder: a multicenter, randomized, double-blind, parallel group comparison.
    Freeman CP; Trimble MR; Deakin JF; Stokes TM; Ashford JJ
    J Clin Psychiatry; 1994 Jul; 55(7):301-5. PubMed ID: 8071291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In-patient treatment for resistant obsessive-compulsive disorder.
    Al-Sughayir MA
    Saudi Med J; 2000 Feb; 21(2):193-5. PubMed ID: 11533781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clomipramine treatment of obsessive compulsive symptomatology in schizophrenic patients.
    Zohar J; Kaplan Z; Benjamin J
    J Clin Psychiatry; 1993 Oct; 54(10):385-8. PubMed ID: 7903293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychotropic drugs and behaviour therapy.
    Stern R
    Practitioner; 1981 Jan; 225(1351):21-5. PubMed ID: 7220458
    [No Abstract]   [Full Text] [Related]  

  • 14. Antiobsessional and antidepressant effects of clomipramine in the treatment of obsessive-compulsive disorder.
    Insel TR; Alterman I; Murphy DL
    Psychopharmacol Bull; 1982 Oct; 18(4):115-7. PubMed ID: 7156271
    [No Abstract]   [Full Text] [Related]  

  • 15. Obsessive compulsive neurosis.
    Sternberg MP
    Practitioner; 1978 Feb; 220(1316):253-7. PubMed ID: 345256
    [No Abstract]   [Full Text] [Related]  

  • 16. Management of treatment-refractory obsessive compulsive disorder patients.
    Dominguez RA; Mestre SM
    J Clin Psychiatry; 1994 Oct; 55 Suppl():86-92. PubMed ID: 7961537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous chlorimipramine in the treatment of obsessional disorder in adolescence: case report.
    Warneke LB
    J Clin Psychiatry; 1985 Mar; 46(3):100-3. PubMed ID: 3972776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A predictive study of obsessive-compulsive disorder response to clomipramine.
    Alarcon RD; Libb JW; Spitler D
    J Clin Psychopharmacol; 1993 Jun; 13(3):210-3. PubMed ID: 8354737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A case of obsessive neurosis (author's transl)].
    Griez EJ
    Acta Psychiatr Belg; 1981; 81(4):366-78. PubMed ID: 7331842
    [No Abstract]   [Full Text] [Related]  

  • 20. D-cycloserine does not enhance exposure-response prevention therapy in obsessive-compulsive disorder.
    Storch EA; Merlo LJ; Bengtson M; Murphy TK; Lewis MH; Yang MC; Jacob ML; Larson M; Hirsh A; Fernandez M; Geffken GR; Goodman WK
    Int Clin Psychopharmacol; 2007 Jul; 22(4):230-7. PubMed ID: 17519647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.